Increasing access to a range of funding mechanisms to support scale-up and translation.
Put world-leading, trusted and accessible healthcare and research data to work
Our progress so far:
- New investment and talent into the ecosystem: ARIA, Automata, BioNtech, Novo Nordisk
- Dedicated Investor Engagement Manager to facilitate relationships with global investors, hosting more than 20 USA venture capitalists
- First UK investment by Flagship Pioneering of £50m into Quotient Therapeutics
What’s next?
- Leverage government funding with charity, philanthropy and industrial partnerships, providing larger pools of seed and growth capital
- Fill the gaps in current funding proposition by attracting new investors to the cluster and supporting investment of UK capital into life sciences
- Increase commercial research and care delivery partnerships
- Develop cross-institutional funding propositions for UK government, philanthropy, industry and venture capitalists